CRO concept sector strengthens, Kelaiying hits the daily limit

MaticHoleFiller · 2026-04-07T08:54:27+00:00

As of 14:50, the CRO concept sector performed strongly, with Kelaiying hitting the daily limit. Stocks such as Chengda Pharmaceutical, Noscage, and Zhaoyan New Drug showed significant gains. Investment should be cautious; please refer to official announcements for specific information.

MaticHoleFiller

2026-04-07 08:54:27

Abstract generation in progress

March 31 news: as of 14:50, the CRO concept sector strengthened. Kaile In was up to its daily limit, and stocks including Chengda Pharmaceuticals, Nuo Sig, and Zhaoyang New Drug saw leading gains.

Statement: The market has risks; investment requires caution. This article is automatically published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is only for reference and does not constitute personal investment advice. If there are any discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—available in the Sina Finance app

Editor: Xiao Lang Express

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.